Korean Botox Brands Compared: Botulax, Nabota, Liztox, Metox

The Korean botulinum toxin market offers European aesthetic professionals multiple KFDA-approved options, each with distinct characteristics, manufacturing processes, and clinical profiles. With five major Korean botox brands now accessible in Europe — Botulax, Nabota, Liztox, Metox, and Innotox — choosing the right product for your practice requires understanding what makes each brand unique.

Botulax (Hugel Inc.)

Botulax is manufactured by Hugel Inc., one of South Korea's largest biopharmaceutical companies with a market capitalization exceeding $1 billion. The company operates state-of-the-art manufacturing facilities in Chuncheon, South Korea, that have been inspected and approved by multiple international regulatory authorities.

Botulax 100U contains Clostridium botulinum toxin type A complexed with human serum albumin and sodium chloride. It is the most widely distributed Korean botulinum toxin globally, with approvals in over 35 countries. Clinical studies have demonstrated non-inferiority to onabotulinumtoxinA, and the product has accumulated an extensive real-world evidence base through millions of treatments worldwide.

Best suited for: Clinics seeking a well-established Korean botulinum toxin with the broadest clinical evidence base and global distribution network. Botulax is often the first Korean brand practitioners try when exploring alternatives to Western products.

Nabota (Daewoong Pharmaceutical)

Nabota holds a unique position as the first Korean botulinum toxin to receive FDA approval (marketed as Jeuveau in the United States). Manufactured by Daewoong Pharmaceutical, Nabota employs the proprietary SMART (Stabilizing Medication through Allergen Removed Technology) purification process, which produces a highly purified toxin preparation.

The FDA approval, based on the extensive TRANSPARENCY clinical trial program, provides an additional layer of regulatory validation that many European practitioners value. Nabota 100U is supplied in a standard vial format with reconstitution requirements similar to other botulinum toxin products.

Best suited for: Clinics that value FDA regulatory validation and want to market their services using an FDA-approved product. The SMART purification technology may also appeal to practitioners concerned about long-term immunogenicity. Read our detailed Nabota guide for European professionals.

Liztox (Huons BioPharma)

Liztox is manufactured by Huons BioPharma, a diversified Korean pharmaceutical company with expertise in biologic products. Liztox 100U contains Clostridium botulinum toxin type A and has gained strong market share in Asian aesthetic markets, particularly in South Korea and Southeast Asia.

Clinical studies have confirmed Liztox's efficacy in treating dynamic facial wrinkles, with safety and efficacy profiles comparable to established botulinum toxin products. The product offers competitive pricing within the Korean botulinum toxin category, making it an attractive option for price-sensitive markets.

Best suited for: Clinics prioritizing value pricing while maintaining KFDA-approved quality. Liztox offers an excellent entry point for clinics beginning to explore Korean botulinum toxin products.

Metox (Medytox Inc.)

Metox is produced by Medytox Inc., the company behind Meditoxin, one of South Korea's original botulinum toxin products. Medytox has over two decades of experience in botulinum toxin manufacturing, giving Metox the benefit of deep expertise in toxin production, purification, and quality control.

Metox 100U is characterized by its consistent potency and reliable clinical performance. Medytox's manufacturing facilities have been subject to extensive regulatory inspection, and the company's long track record provides confidence in product quality and batch-to-batch consistency.

Best suited for: Practitioners who value manufacturing heritage and consistent quality. Medytox's experience as one of South Korea's pioneering botulinum toxin manufacturers provides additional confidence for clinics prioritizing product reliability.

Innotox (Medytox Inc.)

Innotox represents a genuine innovation in the botulinum toxin category as the world's first commercially available liquid (pre-diluted) botulinum toxin. Also manufactured by Medytox, Innotox eliminates the reconstitution step entirely, arriving as a ready-to-use solution that can be administered directly from the vial.

The liquid formulation addresses several practical concerns associated with reconstituted products: it eliminates dilution variability between practitioners, reduces preparation time, and ensures consistent concentration across all treatments. Innotox is supplied in 50-unit vials and must be stored at 2-8 degrees Celsius at all times.

Best suited for: High-volume clinics seeking to reduce preparation time and eliminate reconstitution variability. Practitioners who value consistency in product concentration across all treatments will find Innotox's pre-diluted format particularly appealing. See our complete Innotox guide.

Side-by-Side Comparison